These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8976374)

  • 1. Deletion 5q in desmoid tumor and fluorescence in situ hybridization for chromosome 8 and/or 20 copy number.
    Bridge JA; Meloni AM; Neff JR; Deboer J; Pickering D; Dalence C; Jeffrey B; Sandberg AA
    Cancer Genet Cytogenet; 1996 Dec; 92(2):150-1. PubMed ID: 8976374
    [No Abstract]   [Full Text] [Related]  

  • 2. Trisomies 8 and 20 in desmoid tumors.
    Qi H; Dal Cin P; Hernández JM; Garcia JL; Sciot R; Fletcher C; Van Eyken P; De Wever I; Van den Berghe H
    Cancer Genet Cytogenet; 1996 Dec; 92(2):147-9. PubMed ID: 8976373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some desmoid tumors are characterized by trisomy 8.
    Dal Cin P; Sciot R; Aly MS; Delabie J; Stas M; De Wever I; Van Damme B; Van den Berghe H
    Genes Chromosomes Cancer; 1994 Jun; 10(2):131-5. PubMed ID: 7520266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology.
    De Wever I; Dal Cin P; Fletcher CD; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
    Mod Pathol; 2000 Oct; 13(10):1080-5. PubMed ID: 11048801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone.
    Bridge JA; Swarts SJ; Buresh C; Nelson M; Degenhardt JM; Spanier S; Maale G; Meloni A; Lynch JC; Neff JR
    Am J Pathol; 1999 Mar; 154(3):729-33. PubMed ID: 10079250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormality of chromosome 8 in desmoid-type fibromatosis.
    Yang JL; Wang J; Zhou XY; Li XQ; Zhu XZ
    Chin Med J (Engl); 2007 May; 120(9):838-40. PubMed ID: 17531129
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular cytogenetic analysis of chromosome aberrations in desmoid tumors.
    Mayer M; Kulig A; Sygut J; Dziki A; Simon D; Latos-Bieleńska A; Ferenc T
    Pol J Pathol; 2007; 58(3):167-71. PubMed ID: 18074861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the research of pathology and genetics of desmoid tumor].
    Yang JL; Wang J; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):537-9. PubMed ID: 16383304
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence.
    Fletcher JA; Naeem R; Xiao S; Corson JM
    Cancer Genet Cytogenet; 1995 Feb; 79(2):139-43. PubMed ID: 7889507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 20 is a primary chromosome aberration in desmoid tumors.
    Mertens F; Willén H; Rydholm A; Brosjö O; Carlén B; Mitelman F; Mandahl N
    Int J Cancer; 1995 Nov; 63(4):527-9. PubMed ID: 7591262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
    Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary treatment of desmoid tumours in Gardner's syndrome due to a large interstitial deletion of chromosome 5q.
    Casper M; Petek E; Henn W; Niewald M; Schneider G; Zimmer V; Lammert F; Raedle J
    QJM; 2014 Jul; 107(7):521-7. PubMed ID: 24554300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
    Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
    Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 8 and 20 in desmoid tumors and breast cancer: more than a casual coincidence?
    Rohen G; Bartnitzke S; Bullerdiek J; Bonk U
    Cancer Genet Cytogenet; 1996 Jan; 86(1):92. PubMed ID: 8616800
    [No Abstract]   [Full Text] [Related]  

  • 19. Trisomy 20 characterizes a second group of desmoid tumors.
    Dal Cin P; Sciot R; Van Damme B; De Wever I; Van den Berghe H
    Cancer Genet Cytogenet; 1995 Feb; 79(2):189. PubMed ID: 7889520
    [No Abstract]   [Full Text] [Related]  

  • 20. Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome.
    Dangel A; Meloni AM; Lynch HT; Sandberg AA
    Cancer Genet Cytogenet; 1994 Nov; 78(1):94-8. PubMed ID: 7987814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.